Even though the use of liquid biopsies for cancer screening is still largely undeveloped, a liquid biopsy test based on the detection of abnormal methylation of the SEPTIN9 gene in blood has already been approved to screen for colorectal cancer (CRC) [82]. The gene discussed is SEPTIN9; the disease is cancer.